3646 results for «467»
3646 results
Primary PCI in challenging anatomy
19 May 2026 – From EuroPCR 2026
Focusing on primary PCI in challenging coronary anatomies, this session covers intracoronary thrombolysis for ectasia, imaging-guided no-stent strategies in vein graft occlusions, and management of coronary aneurysms presenting with acute coronary syndromes, highlighting tailored interventional approaches.
Mitral TEER beyond the routine: complex and complicated cases
19 May 2026 – From EuroPCR 2026
This session explores complex and complicated cases of mitral transcatheter edge-to-edge repair (TEER) beyond routine practice. It addresses challenges such as device failures, late complications, acute left ventricular dysfunction related to afterload changes, stepwise approaches to overcome procedural failures, rescue strategies in cardiogenic shock, and tailored...
Pulmonary valve: the next frontier in adult structural interventions
19 May 2026 – From EuroPCR 2026
This session highlights the evolving role of the pulmonary valve in adult structural interventions. It reviews complex transcatheter pulmonary valve replacement (TPVR) cases, strategies for managing challenging right ventricular outflow tract anatomies, and percutaneous solutions for pulmonary artery stenosis and related complications.
New techniques and tips in CTO PCI
19 May 2026 – From EuroPCR 2026
This session presents new techniques and practical tips in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers innovative approaches such as the side-flap technique, simplified antegrade strategies for calcified lesions, and retrograde CTO techniques, providing valuable insights into overcoming challenging occlusions.
Place of DCB in clinical practice
19 May 2026 – From EuroPCR 2026
This session explores the clinical applications of drug-coated balloons (DCB) across diverse challenging scenarios. It covers management of severely calcified nodules in acute coronary syndrome, healing of intentional dissections in chronic total occlusions using paclitaxel DCB, strategic integration of contemporary technology in complex lesion treatment, and...
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)